Association Between Serum Magnesium Levels and Suicidal Behavior in Patients Diagnosed With Depression: A Cross-Sectional Case-Control Study
Abstract
Background: Depression is a common psychiatric illness characterized by persistent low mood, anhedonia, and reduced energy. Severe forms of depression are associated with increased risk of suicidal behavior. Emerging evidence suggests that micronutrient imbalances, including deficiencies in magnesium, vitamin D, zinc, and B-complex vitamins, may influence neuropsychiatric functioning by affecting neurotransmitter synthesis, neuroinflammation, and synaptic plasticity, thereby impacting mood regulation. Methodology: This cross-sectional observational study was conducted at a government medical college in Madhya Pradesh. A total of 200 patients attending the psychiatry outpatient department were enrolled: 100 diagnosed with major depressive disorder and suicidal behavior (case group), and 100 age- and sex-matched patients with depression but without suicidal behavior (control group). Depression severity was assessed using the Hamilton Rating Scale for Depression (HAM-D), and suicidal behavior was evaluated using the Revised Suicidal Behavior Questionnaire (SBQ-R). Ethical approval and informed consent were obtained prior to participation. Results: The mean serum magnesium level was significantly lower in the case group (1.59 ± 0.19 mg/dL) compared to the control group (1.90 ± 0.10 mg/dL, p < 0.001). In both groups, magnesium levels decreased as the severity of depression (measured by the HAM-D scale) increased. A statistically significant negative correlation was found between…
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 200 participants or records.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.